Home
>
National Drug Code (NDC)
>
Nesina
Nesina - 64764-250-50 - (alogliptin)
Drug Information of Nesina
| Product NDC: | 64764-250 |
| Proprietary Name: | Nesina |
| Non Proprietary Name: | alogliptin |
| Active Ingredient(s): | 25 mg/1 & nbsp; alogliptin |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Nesina
| Product NDC: | 64764-250 |
| Labeler Name: | Takeda Pharmaceuticals America, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA022271 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20130125 |
Package Information of Nesina
| Package NDC: | 64764-250-50 |
| Package Description: | 500 TABLET, FILM COATED in 1 BOTTLE (64764-250-50) |
NDC Information of Nesina
| NDC Code | 64764-250-50 |
| Proprietary Name | Nesina |
| Package Description | 500 TABLET, FILM COATED in 1 BOTTLE (64764-250-50) |
| Product NDC | 64764-250 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | alogliptin |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20130125 |
| Marketing Category Name | NDA |
| Labeler Name | Takeda Pharmaceuticals America, Inc. |
| Substance Name | ALOGLIPTIN BENZOATE |
| Strength Number | 25 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes |
